AI assistant
Sending…
REPLIGEN CORP — Director's Dealing 2023
Feb 9, 2023
30826_dirs_2023-02-08_2329605c-7334-41e9-9f56-6cfdabdae207.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2023-02-06
Reporting Person: Madaus Martin D (Director)
More from REPLIGEN CORP
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Interim / Quarterly Report
2026
May 6
Earnings Release
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 27
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23